These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 8376110

  • 1. [Severe type III hyperlipoproteinemia with unusual lipoprotein phenotype in an adolescent patient].
    Ziemer A, Göring HD.
    Hautarzt; 1993 Aug; 44(8):538-44. PubMed ID: 8376110
    [Abstract] [Full Text] [Related]

  • 2. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.
    Feussner G, Dobmeyer J, Nissen H, Hansen TS.
    Am J Med Genet; 1996 Oct 16; 65(2):149-54. PubMed ID: 8911609
    [Abstract] [Full Text] [Related]

  • 3. [From gene to disease; apolipoprotein E2 and familial dysbetalipoproteinemia].
    Smelt AH.
    Ned Tijdschr Geneeskd; 2003 Jan 25; 147(4):157-9. PubMed ID: 12635547
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype.
    Kypreos KE, Li X, van Dijk KW, Havekes LM, Zannis VI.
    Biochemistry; 2003 Aug 26; 42(33):9841-53. PubMed ID: 12924933
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Genetics of type III hyperlipoproteinemia.
    Feussner G, Piesch S, Dobmeyer J, Fischer C.
    Genet Epidemiol; 1997 Aug 26; 14(3):283-97. PubMed ID: 9181357
    [Abstract] [Full Text] [Related]

  • 9. Detailed analysis of serum lipids and lipoproteins from Japanese type III hyperlipoproteinemia with apolipoprotein E2/2 phenotype.
    Todo Y, Kobayashi J, Higashikata T, Kawashiri M, Nohara A, Inazu A, Koizumi J, Mabuchi H.
    Clin Chim Acta; 2004 Oct 26; 348(1-2):35-40. PubMed ID: 15369733
    [Abstract] [Full Text] [Related]

  • 10. The influence of simvastatin alone or in combination with gemfibrozil on plasma lipids and lipoproteins in patients with type III hyperlipoproteinemia.
    Feussner G, Eichinger M, Ziegler R.
    Clin Investig; 1992 Nov 26; 70(11):1027-35. PubMed ID: 1472833
    [Abstract] [Full Text] [Related]

  • 11. Type III dyslipoproteinemia in patients heterozygous for familial hypercholesterolemia and apolipoprotein E2. Evidence for a gene-gene interaction.
    Hopkins PN, Wu LL, Schumacher MC, Emi M, Hegele RM, Hunt SC, Lalouel JM, Williams RR.
    Arterioscler Thromb; 1991 Nov 26; 11(5):1137-46. PubMed ID: 1680391
    [Abstract] [Full Text] [Related]

  • 12. Genetic factors precipitating type III hyperlipoproteinemia in hypolipidemic transgenic mice expressing human apolipoprotein E2.
    Huang Y, Rall SC, Mahley RW.
    Arterioscler Thromb Vasc Biol; 1997 Nov 26; 17(11):2817-24. PubMed ID: 9409260
    [Abstract] [Full Text] [Related]

  • 13. Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2.
    Breslow JL, Zannis VI, SanGiacomo TR, Third JL, Tracy T, Glueck CJ.
    J Lipid Res; 1982 Nov 26; 23(8):1224-35. PubMed ID: 7175379
    [Abstract] [Full Text] [Related]

  • 14. Dysbetalipoproteinaemia--clinical and pathophysiological features.
    Blom DJ, Byrnes P, Jones S, Marais AD.
    S Afr Med J; 2002 Nov 26; 92(11):892-7. PubMed ID: 12506591
    [Abstract] [Full Text] [Related]

  • 15. Influence of apolipoprotein E genotype on the reliability of the Friedewald formula in the estimation of low-density lipoprotein cholesterol concentrations.
    Tremblay AJ, Bergeron J, Gagné JM, Gagné C, Couture P.
    Metabolism; 2005 Aug 26; 54(8):1014-9. PubMed ID: 16092050
    [Abstract] [Full Text] [Related]

  • 16. Carbohydrate intake, serum lipids and apolipoprotein E phenotype show association in children.
    Ruottinen S, Rönnemaa T, Niinikoski H, Lagström H, Saarinen M, Pahkala K, Kaitosaari T, Viikari J, Simell O.
    Acta Paediatr; 2009 Oct 26; 98(10):1667-73. PubMed ID: 19563454
    [Abstract] [Full Text] [Related]

  • 17. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M, McNicoll S, Marcil M, Connelly P, Lussier-Cacan S, Davignon J, Latour Y, Genest J.
    Can J Cardiol; 1997 Mar 26; 13(3):253-60. PubMed ID: 9117913
    [Abstract] [Full Text] [Related]

  • 18. Expression of type III hyperlipoproteinaemia in a subject with secondary hypothyroidism bearing the apolipoprotein E2/2 phenotype.
    Feussner G, Ziegler R.
    J Intern Med; 1991 Aug 26; 230(2):183-6. PubMed ID: 1865171
    [Abstract] [Full Text] [Related]

  • 19. Apolipoprotein E2 (Arg-136-->Cys), a variant of apolipoprotein E associated with late-onset dominance of type III hyperlipoproteinaemia.
    Feussner G, Albanese M, Mann WA, Valencia A, Schuster H.
    Eur J Clin Invest; 1996 Jan 26; 26(1):13-23. PubMed ID: 8682150
    [Abstract] [Full Text] [Related]

  • 20. Effects of atorvastatin and apoA-I/phosphatidylcholine discs on triglyceride-rich lipoprotein subfractions as characterized by capillary isotachophoresis.
    Zhang B, Katafuchi R, Arishima H, Matsunaga A, Rye KA, Saku K.
    Clin Chim Acta; 2006 Nov 26; 373(1-2):55-61. PubMed ID: 16806136
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.